The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 27, 2018

Filed:

Dec. 16, 2015
Applicant:

University of Copenhagen, Copenhagen, DK;

Inventors:

Anders Bach, Valby, DK;

Kristian Stromgaard, Roskilde, DK;

Assignee:

University of Copenhagen, Copenhagen, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 7/06 (2006.01); C07K 5/103 (2006.01); A61K 38/00 (2006.01); A61K 38/07 (2006.01); A61K 38/08 (2006.01); C07K 5/113 (2006.01); C07K 14/705 (2006.01); A61K 47/64 (2017.01);
U.S. Cl.
CPC ...
C07K 7/06 (2013.01); A61K 38/07 (2013.01); A61K 38/08 (2013.01); A61K 47/64 (2017.08); C07K 5/1008 (2013.01); C07K 5/1013 (2013.01); C07K 5/1021 (2013.01); C07K 14/70571 (2013.01); A61K 38/00 (2013.01);
Abstract

The present invention is directed to the provision of small molecule inhibitors of the PSD-95/NMDA receptor interaction, employing an undecapeptide corresponding to the C-terminal of the NMDA as a template for finding lead candidates. A compound (NMDAR/PSD-95 inhibitor) of the invention includes a peptide or peptide analog comprising at least four peptide bonded residues having the sequence YTXV or YSXV, wherein Y is selected from among E, Q, and A, or an analog thereof, and X is selected from among A, Q, D, N, N-Me-A, N-Me-Q, N-Me-D, and N-Me-N or an analog thereof, wherein an amino-terminal residue of the peptide is N-alkylated. Alternatively the compound of the invention comprises a first peptide or peptide analog linked to a second peptide or peptide analog by a linker, where the first and second peptide or peptide analog each comprise at least four peptide bonded residues having the sequence YTXV or YSXV, wherein Y is selected from among E, Q, and A, or an analog thereof, and X is selected from among A, Q, D, N, N-Me-A, N-Me-Q, N-Me-D, and N-Me-N or an analog thereof.


Find Patent Forward Citations

Loading…